Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / SPONSORED ADR
-
Number of holders
-
711
-
Total 13F shares, excl. options
-
205,019,647
-
Shares change
-
-8,280,145
-
Total reported value, excl. options
-
$8,343,354,550
-
Value change
-
-$335,054,699
-
Put/Call ratio
-
64.29%
-
Number of buys
-
328
-
Number of sells
-
-294
-
Price
-
$40.55
Significant Holders of GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) as of Q1 2016
788 filings reported holding GSK - GLAXOSMITHKLINE PLC - SPONSORED ADR as of Q1 2016.
GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) has 711 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 205,019,647 shares
.
Largest 10 shareholders include FMR LLC (15,944,140 shares), Fisher Asset Management, LLC (11,657,855 shares), WELLS FARGO & COMPANY/MN (11,484,346 shares), JPMORGAN CHASE & CO (10,452,726 shares), STATE STREET CORP (10,361,271 shares), ROYAL BANK OF CANADA (8,959,457 shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (8,915,323 shares), PRICE T ROWE ASSOCIATES INC /MD/ (6,944,865 shares), Bank of New York Mellon Corp (5,940,899 shares), and FEDERATED INVESTORS INC /PA/ (5,628,165 shares).
This table shows the top 711 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.